Molecular characterisation of a panel of human ovarian carcinoma xenografts

被引:17
|
作者
Codegoni, AM
Nicoletti, MI
Buraggi, G
Valoti, G
Giavazzi, R
D'Incalci, M
Landoni, F
Maneo, A
Broggini, M
机构
[1] Mario Negri Inst Pharmacol Res, I-20157 Milan, Italy
[2] Mario Negri Inst Pharmacol Res, I-24125 Bergamo, Italy
[3] Univ Milan, Osped San Gerardo, Monza, MI, Italy
关键词
ovarian cancer; xenografts; cell cycle proteins; DNA repair; drug resistance;
D O I
10.1016/S0959-8049(98)00075-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In a panel of 16 human ovarian tumours transplanted in nude mice, the expression of genes involved in cell cycle regulation and in response to drug treatment were characterised. In the 16 tumours analysed we could not detect overexpression of Erb-B2 oncogene while expression of MDR1 mRNA was not detected in 11/15 samples and was low in 4/15 tumours. Only three tumours had mutations in the p53 gene exons 5-8 and one of these mutations did not result in any amino acid alteration. The levels of mRNA for cyclins A, D1 and E were heterogeneous with some tumours expressing high levels and others not expressing them at all. The same was found for the cyclin dependent kinases (CDK) CDK2 and CDK4 and for CDK inhibitors P21/WAF1, p27/KIP1 and p16/CDKN2. Two genes belonging to the nucleotide excision repair, ERCC1 and ERCC3 were detectable in all the samples examined, as were the genes MGMT and MAG, also involved in DNA repair. The data indicate a heterogeneity in the expression of genes considered to be involved in the cellular responses to cytotoxic drug treatment and indicate the possibility of using these tumour models to test specifically molecules with a defined mechanism of action. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1432 / 1438
页数:7
相关论文
共 50 条
  • [31] Selenium compounds prevent the induction of drug resistance by cisplatin in human ovarian tumor xenografts in vivo
    Caffrey, PB
    Frenkel, GD
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2000, 46 (01) : 74 - 78
  • [32] Molecular determinants of tumor differentiation in papillary serous ovarian carcinoma
    Jazaeri, AA
    Lu, K
    Schmandt, R
    Harris, CP
    Rao, PH
    Sotiriou, C
    Chandramouli, GVR
    Gershenson, DM
    Liu, ET
    MOLECULAR CARCINOGENESIS, 2003, 36 (02) : 53 - 59
  • [33] Quantitative analysis of the human ovarian carcinoma mitochondrial phosphoproteome
    Li, Na
    Qian, Shehua
    Li, Biao
    Zhan, Xianquan
    AGING-US, 2019, 11 (16): : 6449 - 6468
  • [34] The multiple facets of ovarian high grade serous carcinoma: A review on morphological, immunohistochemical and molecular features
    Santoro, Angela
    Angelico, Giuseppe
    Travaglino, Antonio
    Inzani, Frediano
    Spadola, Saveria
    Pettinato, Angela
    Mazzucchelli, Manuel
    Bragantini, Emma
    Maccio, Livia
    Zannoni, Gian Franco
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2025, 208
  • [35] Molecular Management of High-Grade Serous Ovarian Carcinoma
    Punzon-Jimenez, Paula
    Lago, Victor
    Domingo, Santiago
    Simon, Carlos
    Mas, Aymara
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (22)
  • [36] Hereditary ovarian carcinoma: Heterogeneity, molecular genetics, pathology, and management
    Lynch, Henry T.
    Casey, Murray Joseph
    Snyder, Carrie L.
    Bewtra, Chhanda
    Lynch, Jane F.
    Butts, Matthew
    Godwin, Andrew K.
    MOLECULAR ONCOLOGY, 2009, 3 (02) : 97 - 137
  • [37] Novel ABCG2 Antagonists Reverse Topotecan-Mediated Chemotherapeutic Resistance in Ovarian Carcinoma Xenografts
    Ricci, Jerec W.
    Lovato, Debbie M.
    Severns, Virginia
    Sklar, Larry A.
    Larson, Richard S.
    MOLECULAR CANCER THERAPEUTICS, 2016, 15 (12) : 2853 - 2862
  • [38] Clinical relevance of human cancer xenografts as a tool for preclinical assessment: example of in-vivo evaluation of topotecan-based chemotherapy in a panel of human small-cell lung cancer xenografts
    Nemati, Fariba
    Daniel, Catherine
    Arvelo, Francisco
    Legrier, Marie-Emmanuelle
    Froget, Benoit
    Livartowski, Alain
    Assayag, Franck
    Bourgeois, Yveline
    Poupon, Marie-France
    Decaudin, Didier
    ANTI-CANCER DRUGS, 2010, 21 (01) : 25 - 32
  • [39] Proteomic analysis of human epithelial ovarian cancer xenografts in immunodeficient mice exposed to chronic psychological stress
    GAO Jun1
    2Department of Gynecology
    Science China(Life Sciences), 2011, (02) : 112 - 120
  • [40] Rapid development of drug resistance in human ovarian tumor xenografts after a single treatment with melphalan in vivo
    Caffrey, PB
    Zhang, YX
    Frenkel, GD
    ANTICANCER RESEARCH, 1998, 18 (4C) : 3021 - 3025